IRIS
MERLOTTI, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.535
EU - Europa 4.686
AS - Asia 3.351
SA - Sud America 618
AF - Africa 126
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 15.331
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.423
CN - Cina 1.123
SG - Singapore 1.092
RU - Federazione Russa 1.082
GB - Regno Unito 795
IE - Irlanda 735
BR - Brasile 512
IT - Italia 426
UA - Ucraina 389
SE - Svezia 335
VN - Vietnam 331
FR - Francia 310
HK - Hong Kong 263
DE - Germania 262
KR - Corea 172
FI - Finlandia 160
IN - India 91
ZA - Sudafrica 66
CA - Canada 58
AR - Argentina 45
BD - Bangladesh 45
ES - Italia 36
TR - Turchia 36
NL - Olanda 34
IQ - Iraq 28
MX - Messico 26
JP - Giappone 23
PL - Polonia 23
BE - Belgio 20
PK - Pakistan 19
SA - Arabia Saudita 17
ID - Indonesia 15
LT - Lituania 15
CI - Costa d'Avorio 14
CL - Cile 14
AT - Austria 12
EC - Ecuador 11
NP - Nepal 11
UZ - Uzbekistan 11
CZ - Repubblica Ceca 10
KE - Kenya 10
VE - Venezuela 10
CO - Colombia 8
IR - Iran 8
MY - Malesia 8
NG - Nigeria 8
JO - Giordania 7
DO - Repubblica Dominicana 6
EU - Europa 6
HU - Ungheria 6
PE - Perù 6
TH - Thailandia 6
AZ - Azerbaigian 5
DK - Danimarca 5
GR - Grecia 5
IL - Israele 5
MA - Marocco 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CH - Svizzera 4
EG - Egitto 4
ET - Etiopia 4
OM - Oman 4
PA - Panama 4
PH - Filippine 4
BB - Barbados 3
BO - Bolivia 3
CR - Costa Rica 3
DZ - Algeria 3
GE - Georgia 3
HN - Honduras 3
JM - Giamaica 3
KZ - Kazakistan 3
PT - Portogallo 3
PY - Paraguay 3
RS - Serbia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
LU - Lussemburgo 2
LV - Lettonia 2
MW - Malawi 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RO - Romania 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
EE - Estonia 1
GA - Gabon 1
Totale 15.317
Salva come PNG Salva come JPEG
Città #
Dallas 786
Dublin 726
Fairfield 692
Southend 639
Singapore 561
Ashburn 463
Santa Clara 381
Chandler 319
Jacksonville 309
Woodbridge 304
Moscow 283
Houston 267
Beijing 252
Hong Kong 250
Wilmington 248
Cambridge 241
Seattle 238
Hefei 214
San Jose 214
Ann Arbor 179
Seoul 170
Princeton 138
The Dalles 117
Ho Chi Minh City 101
Los Angeles 101
Council Bluffs 100
Nanjing 92
Siena 87
Lauterbourg 86
Helsinki 80
Hanoi 74
Johannesburg 56
Boardman 48
New York 48
Buffalo 46
Shanghai 45
London 43
Munich 43
Nanchang 43
San Diego 43
Milan 41
São Paulo 39
Dong Ket 36
San Mateo 30
Dearborn 27
Rome 27
Tianjin 27
Shenyang 26
Columbus 25
Redondo Beach 25
Da Nang 24
Izmir 24
Orem 24
San Francisco 23
Bengaluru 22
Montreal 21
Brussels 20
Tokyo 20
Málaga 19
Redwood City 19
Warsaw 19
Denver 18
Brooklyn 17
Düsseldorf 17
Hebei 17
Kunming 17
Chicago 16
Jiaxing 16
Toronto 16
Boston 15
Changsha 15
Rio de Janeiro 15
Abidjan 14
Turku 14
Venezia 14
Belo Horizonte 13
Chennai 13
Frankfurt am Main 13
Poplar 13
Florence 12
Haiphong 12
Manchester 12
Nuremberg 12
Riyadh 12
Amsterdam 11
Mumbai 11
Naples 11
Norwalk 11
Porto Alegre 11
Portsmouth 11
Stockholm 11
Bologna 10
Brasília 10
Fremont 10
Guangzhou 10
Hangzhou 10
Atlanta 9
Phoenix 9
Tashkent 9
Zhengzhou 9
Totale 10.161
Salva come PNG Salva come JPEG
Nome #
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes 306
Comparison of intravenous and intramuscular neridronate regimens for the treatment of Paget disease of bone 268
Aromatase activity and bone loss in men 252
A non-synonymous TNFRSF11A variation increases NFkB activity and the severity of Paget's disease 247
Bazedoxifene for the prevention of postmenopausal osteoporosis 244
Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone. 241
Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease 237
The association of body composition and sexhormones with quantitative ultrasound parameters at the calcaneus and phalanxes in elderly women. 234
ZNF687 Mutations in Severe Paget Disease of Bone Associated with Giant Cell Tumor 224
Variation in Bone Turnover Markers in Professional Sport Players During Training is Mediated by Changes in Sclerostin Levels 222
The usefulness of quantitative ultrasound (QUS) measurements in the evaluation of skeletal status in newborns and in children 218
Endocrine actions of osteocalcin 218
Corretto uso dei marcatori del rimodellamento osseo 215
Aromatase activity and bone loss 214
Bone metabolism in men: role of aromatase activity 208
Longitudinal association between sex hormone levels, bone loss and bone turnover in elderly men. 202
Appropriate models for novel osteoporosis drug discovery and future perspectives 199
Mutation of PFN1 gene in an early onset, polyostotic Paget-like disease 198
SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone 197
The influence of weight and length at birth on bone status during childhood as evaluated by QUS 195
Mild brachydactyly type A1 maps to chromosome 2q35-q36 and is caused by a novel IHH mutation in a three generation family 192
Lasofoxifene, from the preclinical drug discovery to the treatment of postmenopausal osteoporosis 192
CALCITRIOLO E OSTEOPOROSI 190
Update on the pathogenesis and genetics of Paget's disease of bone 189
The effects of zoledronic acid on serum lipids in multiple myeloma patients 189
Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function 187
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene 185
Vitamin D receptor gene polymorphisms predict acquired resistance to clodronate treatment in patients with Paget's disease of bone 185
Analysis of Usual Consumption of Vitamin D Among Adult Individuals in Italy 184
Aromatase deficiency and male osteoporosis 182
Preventive Role of Vitamin D Supplementation for Acute Phase Reaction after Bisphosphonate Infusion in Paget's Disease 176
Vescicole extracellulari e metabolismo osseo: ruolo e possibili implicazioni cliniche 175
Pharmacokinetic evaluation of toremifene and its clinical implications for the treatment of osteoporosis 175
Epidemiological, clinical, and genetic characteristics of Paget's disease of bone in a rural area of Calabria, Southern Italy 174
Giant cell tumor occurring in familial Paget's disease of bone: report of clinical characteristics and linkage analysis of a large pedigree 174
The use of intravenous aminobisphosphonates for the treatment of Paget's disease of bone 172
Quantitative ultrasound and dual-energy X-ray absorptiometry in the prediction of fragility fracture in men 171
Apporto nutrizionale di vitamina D in Italia [Feeding and vitamin D in Italy] 170
Feasibility of quantitative ultrasound measurements on the humerus of newborn infants for the assessment of the skeletal status. 169
Update on the pharmacogenetics of the vitamin D receptor and osteoporosis 169
Infection by CagA-Positive Helicobacter pylori Strains and Bone Fragility: A Prospective Cohort Study 168
Mechanisms of impaired bone strength in type 1 and 2 diabetes 166
Prevalence of Paget’s disease of bone in Italy 166
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels 165
Paget's disease of bone: epidemiology, pathogenesis and pharmacotherapy 164
MicroRNAs in bone diseases 164
Lasofoxifene: a third-generation selective estrogen receptor modulator for the prevention and treatment of osteoporosis 160
Bone fragility in men: where are we? 159
Vitamin D Status in Paget Disease of Bone and Efficacy-Safety Profile of Cholecalciferol Treatment in Pagetic Patients with Hypovitaminosis D. 159
Perspectives in the treatment and prevention of osteoporosis 158
Lasofoxifene: a new-generation SERM for the treatment of postmenopausal osteoporosis 157
Ospemifene use in postmenopausal women 156
Effects of Bisphosphonate Treatment on Circulating Lipid and Glucose Levels in Patients with Metabolic Bone Disorders 155
Dietary Vitamin D Intake in Italian Subjects: Validation of a Frequency Food Questionnaire (FFQ) 154
Identification of Single Nucleotide Polymorphisms (SNPs) contributing to bone mineral density and fractures: a DNA microarray based study 150
FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women 149
Role of Advanced Glycation End-Products and Oxidative Stress in Type-2-Diabetes-Induced Bone Fragility and Implications on Fracture Risk Stratification 148
Recent advances in models for screening potential osteoporosis drugs 146
Lasofoxifene: Evidence of its therapeutic value in osteoporosis 145
Steroid hormone receptor gene polymorphisms and osteoporosis: a pharmacogenomic review 145
Interleukin-6 trans-signaling and pathological low back pain in patients with Paget disease of bone 141
Raloxifene in breast cancer prevention 140
Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes 139
Vitamin D Deficiency in COVID-19 Patients and Role of Calcifediol Supplementation 138
Vitamin D deficiency and primary hyperparathyroidism 138
Cortisol secretion, sensitivity, and activity are associated with hypertension in postmenopausal eucortisolemic women 137
Relationship of sex hormones with bone turnover markers, bone ultrasounds and BMD at multiple sites in men and women 136
The Potential Role of miRNAs as New Biomarkers for Osteoporosis 133
Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy 131
Treatment options for glucocorticoid-induced osteoporosis 131
Drug treatment strategies for paget’s disease: relieving pain and preventing progression 128
null 128
Current options for the treatment of Paget's disease of the bone 127
Diagnosis and treatment of Paget’s disease of bone: position paper from the Italian Society of Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS) 123
Micro-RNA expression profiling in Paget's disease of bone 123
Emerging therapeutic targets for osteoporosis 123
MANAGEMENT STRATEGIES FOR OSTEOPOROSIS IN THE AGING MALE: FOCUS ON ZOLEDRONIC ACID 122
null 122
Selective estrogen receptor modulators for postmenopausal osteoporosis: current state of development 119
Professional sport activity and micronutrients: effects on bone mass 119
Oncogenic osteomalacia 115
Paget’s disease of bone: an update on epidemiology, pathogenesis and pharmacotherapy 114
la genetica dell'osteoporosi 113
Clinical Characteristics and Evolution of Giant Cell Tumor Occurring in Paget's Disease of Bone 113
Paget's disease of bone 113
Efficacy and safety of abaloparatide for the treatment of post-menopausal osteoporosis 112
Hypovitaminosis D and organ damage in patients with arterial hypertension: a multicenter double blind randomised controlled trial of cholecalciferol supplementation (HYPODD) : study design, clinical procedures and treatment protocol 109
Treatment needs and current options for postmenopausal osteoporosis 107
null 105
null 103
Management of bone fragility in type 2 diabetes:Perspective from an interdisciplinary expert panel 99
Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility 99
Energy metabolism and ketogenic diets: What about the skeletal health? a narrative review and a prospective vision for planning clinical trials on this issue 92
Validation of the clinical consensus recommendations on the management of fracture risk in postmenopausal women with type 2 diabetes 87
Prediction of hypertension, diabetes and fractures in eucortisolemic women by measuring parameters of cortisol milieu 84
Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosis 73
Totale 15.509
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.474
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.474
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202187 0 0 0 0 0 0 0 0 0 0 0 87
2021/2022855 52 107 41 109 24 25 36 23 44 105 88 201
2022/20231.233 81 90 184 164 120 262 26 95 117 33 40 21
2023/20241.157 123 48 112 45 19 245 389 17 7 28 33 91
2024/20252.610 47 128 188 128 382 189 96 149 234 121 243 705
2025/20265.238 503 863 566 643 978 252 555 151 185 321 160 61
Totale 15.509